Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection
JAMA · 13.08.2024 · 332 (6) · 501
DOI: 10.1001/jama.2024.11174 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 13.08.2024. Verfasst von Nadine Friedl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Diabetes Research, Helmholtz Munich, Munich, Germany. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus, Type 1, Disease Progression. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
This study examines whether an association exists between COVID-19 infection and progression to clinical diabetes among youth with presymptomatic type 1 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Diabetes Research, Helmholtz Munich, Munich, Germany.
- Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany.
Zitieren
APA
Friedl, N., Sporreiter, M., Winkler, C., Heublein, A., Haupt, F., Ziegler, A. G., Bonifacio, E., & Fr1da Study Group (2024). Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection. JAMA, 332(6), 501. https://doi.org/10.1001/jama.2024.11174
Vancouver
Friedl N, Sporreiter M, Winkler C, Heublein A, Haupt F, Ziegler AG, et al. Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection. JAMA. 2024;332(6):501. doi:10.1001/jama.2024.11174
BibTeX
@article{Friedl2024,
author = {Friedl, Nadine and Sporreiter, Melanie and Winkler, Christiane and Heublein, Anja and Haupt, Florian and Ziegler, Anette-Gabriele and Bonifacio, Ezio and Fr1da Study Group, Fr1da Study Group},
title = {Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection},
journal = {JAMA},
year = {2024},
volume = {332},
number = {6},
pages = {501},
doi = {10.1001/jama.2024.11174}
}
EUVIMED